CoChat

Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light (NFL) and total tau are elevated in Huntington's disease (HD) and may be used as markers of disease stage. Biomarkers are needed due to the slow disease progression and the limitations of clinical assessment. This study aims to validate the role of NFL and tau as biomarkers in HD. METHODS: CSF was obtained from a cohort of HD patients and premanifest HD-mutation carriers. Unified Huntington's Disease Rating Scale (UHDRS) testing was performed on all subjects at the time of sampling. NFL and tau concentrations were determined by ELISA. Spearman correlations were calculated with R version 3.2.3. RESULTS: 11 premanifest HD and 12 manifest HD subjects were enrolled. NFL and tau levels were correlated. NFL showed strong correlations with all items included in the clinical assessment (for example the total functional capacity (TFC) (r = - 0.70 p < 0.01) and total motor score (TMS) (r = 0.83p < 0.01). Tau showed slightly weaker correlations (eg. TMS (r = 0.67 p < 0.01); TFC (r = - 0.59 p < 0.01)). NFL was significantly correlated with 5-year probability of disease onset, whereas tau was not. CONCLUSION: This study strengthens the case for NFL as a useful biomarker of disease stage. NFL was strongly correlated to all evaluated items in the UHDRS assessment. Tau also has a potential for use as a biomarker but correlations to clinical tests are weaker in this study. We suggest that NFL and possibly tau be used in clinical drug trials as biomarkers of disease progression that are potentially influenced by future disease-modifying therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0172762

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Correlations between NFL and disease progression in Huntington’s disease. (A) Neurofilament light (NFL) and tau levels are significantly correlated. NFL correlates positively with (B) disease burden and (C) 5-year probability of disease onset but negatively with (D) total functional capacity. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.
Fig 1 Correlations between NFL and disease progression in Huntington’s disease. (A) Neurofilament light (NFL) and tau levels are significantly correlated. NFL correlates positively with (B) disease burden and (C) 5-year probability of disease onset but negatively with (D) total functional capacity. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.CC BY · PubMed Central
Fig 2 Correlations between tau and disease progression in Huntington’s disease. Tau does not correlate with (A) 5-year probalility of disease onset but correlations with (B) disease burden, (C) total functional capacity, and (D) total motor score were significant. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.
Fig 2 Correlations between tau and disease progression in Huntington’s disease. Tau does not correlate with (A) 5-year probalility of disease onset but correlations with (B) disease burden, (C) total functional capacity, and (D) total motor score were significant. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.CC BY · PubMed Central
Fig 3 Comparing the correlations of neurofilament light and tau with cognitive test scores. Neurofilament light (NFL) has stronger correlations with clinical scores like (A) stroop interferens, and (B) category fluency, compared with (C and D) tau. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.
Fig 3 Comparing the correlations of neurofilament light and tau with cognitive test scores. Neurofilament light (NFL) has stronger correlations with clinical scores like (A) stroop interferens, and (B) category fluency, compared with (C and D) tau. ○ Premanifest gene expansion carrier • Manifest Huntington’s disease.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 64

Metadata

Authors
Niemelä, V., Landtblom, A.-M., Blennow, K., & Sundblom, J.
Affiliations
  • Uppsala University (SE)
  • University of Gothenburg (SE)
Corresponding author
Niemelä, Valter
Venue
PLOS ONE
Published
2017-02-27
Volume
12
Issue
2
Pages
e0172762
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2592956615
Cited by
63
References
31
Citations by year
2026: 4 · 2025: 6 · 2024: 11 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 1
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Åland Cultural Foundation
  • The Selander Foundation
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
Huntington's disease, neurofilament light chain, total tau, cerebrospinal fluid biomarkers, premanifest Huntington's disease, disease stage, disease progression, Unified Huntington's Disease Rating Scale, disease-modifying therapy
MeSH terms
Adult, Aged, Axons, Enzyme-Linked Immunosorbent Assay, Female, Humans, Huntington Disease, Male, Middle Aged, Mutation, Cohort Studies, Biomarkers, tau Proteins, Neurofilament Proteins, Disease Progression, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.